Related Experiment Videos
[Effects of BY-1949 on three kinds of experimental amnesia in rodents]
1Exploratory Research Laboratories, Chugai Pharmaceutical Co. Ltd., Shizuoka, Japan.
Abstract:
The possible anti-amnesic effects of a dibenzoxazepine derivative, BY-1949 (3-methoxy-11-methyldibenz[b,f] [1, 4] oxazepine-8-carboxylate), were examined using the three learning paradigms. In the one-trial passive avoidance task in mice, BY-1949 (1-30 mg/kg, po) and aniracetam (3-30 mg/kg, po) reversed the shortening of the response latency in the retention test produced by exposure to 100% CO2 immediately after the acquisition trial. In the two-way active avoidance task in rats, BY-1949 (10, 30 mg/kg, po) reversed the decreased avoidance rate produced by the hypoxia treatment (5% O2:95% N2). In the radial-arm maze task in rats, BY-1949 (10 mg/kg, po) and aniracetam (10, 30 mg/kg, po) improved the impaired correct choices induced by scopolamine (0.25 mg/kg, ip). These results suggest that BY-1949, as well as aniracetam, exerts some improvement effects on experimental amnesia.
Insights
The novel compound BY-1949 demonstrated anti-amnesic effects, improving memory in mice and rats across multiple learning tasks. This dibenzoxazepine derivative shows potential for treating experimental amnesia.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Amnesia is a memory impairment with various causes.
- Developing effective treatments for amnesia is a significant challenge in neuroscience.
- Dibenzoxazepine derivatives are being investigated for their potential therapeutic properties.
Purpose of the Study:
- To evaluate the anti-amnesic effects of a dibenzoxazepine derivative, BY-1949.
- To compare the efficacy of BY-1949 with aniracetam, a known nootropic agent.
- To assess BY-1949's impact on memory in established animal models of amnesia.
Main Methods:
- One-trial passive avoidance task in mice using CO2-induced amnesia.
- Two-way active avoidance task in rats using hypoxia-induced amnesia.
- Radial-arm maze task in rats using scopolamine-induced amnesia.
Main Results:
- BY-1949 reversed memory deficits caused by CO2 exposure in mice.
- BY-1949 improved avoidance rates in rats subjected to hypoxia.
- BY-1949 enhanced cognitive performance in rats with scopolamine-induced amnesia, similar to aniracetam.
Conclusions:
- BY-1949 exhibits significant anti-amnesic properties.
- The compound demonstrates efficacy across different models of experimental amnesia.
- BY-1949 represents a potential therapeutic candidate for memory disorders.